The effect of pretreatment with an AMPA receptor antagonist, NBQX, on
MK-801-induced alterations in glucose use was examined using [C-14]-2-
deoxyglucose autoradiography. NBQX (7 mg/kg) had minimal effect on glu
cose utilisation in all anatomical regions examined. The intravenous a
dministration of MK-801 (0.2 mg/kg) induced increases in glucose use i
n the limbic system and cingulate cortex. MK-801 reduced glucose utili
sation in the sensory motor and auditory cortices. Pretreatment with N
BQX attenuated the MK-801-induced hypermetabolism in the posterior cin
gulate cortex. The decreases in glucose utilisation induced by MK-801
were not exacerbated by the pretreatment with NBQX. The interaction be
tween NBQX and MK-801 suggests a possible method of attenuating some o
f the adverse effects of the non-competitive NMDA receptor antagonists
in the posterior cingulate cortex.